+44 (0) 1223 755950
+1 832 327 7413
Click on the image to see the image legend
Target | Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein RBD (Delta B.1.617.2 Variant) |
Target Modification | Lys452Arg, Thr478Lys |
Modification | Mutation |
Origin | Virus |
Expression | Recombinant |
Tested Applications | SDS-PAGE |
Host | Mammalian cells |
Recommended dilutions | Optimal dilutions/concentrations should be determined by the end user. |
Conjugation | Unconjugated |
Form | Lyophilized |
Purity | > 90% (SDS-PAGE) |
Reconstitution | Reconstitute in ddH2O to a concentration of 1 mg/ml. |
Storage | Store between -20 °C and -80 °C. Avoid repeated freeze/thaw cycles. |
NCBI Accession | YP_009724390.1 |
Molecular Weight | Observed MW: 35 kDa |
Tag | C-terminal His tag |
Buffer | Prior to lyophilization: PBS, pH 7.4, containing 1 mM EDTA, 4% Trehalose and 1% Mannitol. |
Concentration | Prior to lyophilization: 1.48 mg/ml |
Availability | Shipped within 5-10 working days. |
Note | This product is for research use only. Not for human consumption, cosmetic, therapeutic or diagnostic use. |